1. Home
  2. HWKN vs BLLN Comparison

HWKN vs BLLN Comparison

Compare HWKN & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hawkins Inc.

HWKN

Hawkins Inc.

HOLD

Current Price

$152.99

Market Cap

3.3B

ML Signal

HOLD

BLLN

BillionToOne Inc.

N/A

Current Price

$87.17

Market Cap

3.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HWKN
BLLN
Founded
1938
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Chemicals
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.9B
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
HWKN
BLLN
Price
$152.99
$87.17
Analyst Decision
Buy
Buy
Analyst Count
2
6
Target Price
$200.00
$137.83
AVG Volume (30 Days)
159.3K
259.9K
Earning Date
01-28-2026
12-09-2025
Dividend Yield
0.50%
N/A
EPS Growth
1.59
N/A
EPS
3.97
N/A
Revenue
$1,045,229,000.00
$254,136,000.00
Revenue This Year
$14.22
$98.01
Revenue Next Year
$7.46
$35.84
P/E Ratio
$38.30
N/A
Revenue Growth
11.86
254.30
52 Week Low
$98.30
$80.51
52 Week High
$186.15
$138.70

Technical Indicators

Market Signals
Indicator
HWKN
BLLN
Relative Strength Index (RSI) 56.88 N/A
Support Level $144.95 N/A
Resistance Level $156.17 N/A
Average True Range (ATR) 5.38 0.00
MACD 0.12 0.00
Stochastic Oscillator 55.97 0.00

Price Performance

Historical Comparison
HWKN
BLLN

About HWKN Hawkins Inc.

Hawkins Inc manufactures and sells a variety of chemicals and ingredients. The firm organizes itself into three segments based on the product type. The industrial segment, which generates the majority of revenue, sells private label bleach, caustic soda, sulfuric acid, hydrochloric acid, phosphoric acid, potassium hydroxide, and aqua ammonia. The water treatment segment sells chemicals and equipment used to treat potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. The health and nutrition segment sells ingredients to food, beverage, personal care, and dietary supplement producers. The majority of revenue is gained from Water Treatment.

About BLLN BillionToOne Inc.

BillionToOne Inc is a precision diagnostics company revolutionizing molecular testing with its patented Quantitative Counting Templates (QCT) platform. This technology enables ultrasensitive, single-molecule DNA quantification, making genetic testing more accurate, affordable, and accessible. The company serves prenatal screening and oncology markets with non-invasive tests that detect fetal genetic risks and monitor cancer therapy response.

Share on Social Networks: